Frequent allelic loss at the FRA3B site in endemic nasopharyngeal carcinoma: Association with clinical features and Epstein-Barr virus infection

Journal of Laryngology and Otology

Volumn 121, Issue 11, 2007, Pages 1073-1078

  Deng, Y F ^a   Zhou, D N ^a   Lu, Y D ^b  

^a XIAMEN UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Carcinoma; Chromosome Fragile Sites; Nasopharyngeal Neoplasms

Indexed keywords

IMMUNOGLOBULIN A; PROTEIN FRA3B; TUMOR PROTEIN; CAPSID PROTEIN; EPSTEIN BARR VIRAL CAPSID ANTIGEN; EPSTEIN-BARR VIRAL CAPSID ANTIGEN; MICROSATELLITE DNA; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ALLELE; ANTIBODY TITER; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DNA FLANKING REGION; ENDEMIC DISEASE; EPSTEIN BARR VIRUS; FEMALE; GENE DELETION; GENE FREQUENCY; GENE LOCUS; GENETIC POLYMORPHISM; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MALE; NASOPHARYNX CARCINOMA; TUMOR DIFFERENTIATION; VIRUS INFECTION; CARCINOMA; CHINA; CHROMOSOME FRAGILE SITE; GENETICS; HETEROZYGOSITY LOSS; IMMUNOLOGY; METASTASIS; NASOPHARYNX TUMOR; PATHOLOGY;

ANTIGENS, VIRAL; CAPSID PROTEINS; CARCINOMA; CHINA; CHROMOSOME FRAGILE SITES; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; LYMPHATIC METASTASIS; MALE; MICROSATELLITE REPEATS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING;

EID: 41449103229     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215107006445     Document Type: Article

References (23)

1. Li X, Wang E, Zhao YD, Ren JQ, Jin P, Yao KT et al. Chromosomal imbalances in nasopharyngeal carcinoma: a meta-analysis of comparative genomic hybridization results. J Transl Med 2006;4:1-9
2. Burgos JS. Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis. Med Oncol 2005;22:113-21
3. Chan AT, Teo PM, Huang DP. Pathogenesis and treatment of nasopharyngeal carcinoma. Semin Oncol 2004;31:794-801
4. Lo KW, Huang DP. Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin Cancer Biol 2002;12:451-62
5. Becker NA, Thorland EC, Denison SR, Phillips LA, Smith DI. Evidence that instability within the FRA3B region extends four megabases. Oncogene 2002;21:8713-22
6. Fang JM, Arlt MF, Buegess AC, Dagenais SL, Beer DG, Glover TW. Translocation breakpoints in FHIT and FRA3B in both homologs of chromosome 3 in an esophageal adenocarcinoma. Genes Chromosomes Cancer 2001;30:292-8
7. Corbin S, Neilly ME, Espinosa R 3rd, Davis EM, McKeithan TW, Le Beau MM. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors. Cancer Res 2002;62:3477-84
8. Kameoka Y, Tagawa H, Tsuzuki S, Karnan S, Ota A, Suguro M et al. Contig array CGH at 3p14.2 points to the FRA3B/FHIT common fragile region as the target gene in diffuse large B-cell lymphoma. Oncogene 2004;23:9148-54
9. Huebner K, Croce CM. Cancer and the FRA3B/FHIT fragile locus: it's a hit. Br J Cancer 2003;88:1501-6
10. Deng YF, Tian F, Lu YD, Chen ZC, Xie DH, Yang XM et al. Mutation and abnormal expression of the fragile histidine triad gene in nasopharyngeal carcinoma. Laryngoscope 2001;111:1589-92
11. Yuge T, Nibu K, Kondo K, Shibahara J, Tayama N, Sugasawa M. Loss of FHIT expression in squamous cell carcinoma and premalignant lesions of the larynx. Ann Otol Rhinol Laryngol 2005;114:127-31
12. Thavathiru E, Ludes-Meyers JH, Macleod MC, Aldaz CM. Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR. Mol Carcinog 2005;44:174-82
13. Shao JY, Zeng WF, Zeng YX. Molecular genetic progression on nasopharyngeal carcinoma [in Chinese]. Chin J Cancer 2002;21:1-10
14. Kuroki T, Tajima Y, Furui J, Kanematsu T. Common fragile genes and digestive tract cancers. Surg Today 2006;36:1-5
15. Michael D, Rajewsky MF. Induction of the common fragile site FRA3B does not affect FHIT expression. Oncogene 2001;20:1798-801
16. Sung NS, Zeng Y, Raab-Traub N. Alterations on chromosome 3 in endemic and nonendemic nasopharyngeal carcinoma. Int J Cancer 2000;86:244-50
17. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning: a Laboratory Manual, 2nd edn. New York: Cold Spring Harbor Laboratory Press, 1989;916-20
18. Kuroki T, Trapasso F, Yendamuri S, Matsuyama A, Alder H, Mori M et al. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res 2003;63:3724-8
19. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996;84:587-97
20. Yan W, Song L, Wei W, Li A, Liu J, Fang Y. Chromosomal abnormalities associated with neck nodal metastasis in nasopharyngeal carcinoma. Tumour Biol 2005;26:306-12
21. Mutirangura A, Tanunyutthawongese C, Pornthanakasem W, Kerekhanjanarong V, Sriuranpong V, Yenrudi S et al. Genomic alterations in nasopharyngeal carcinoma: loss of heterozygosity and Epstein-Barr virus infection. Br J Cancer 1997;76:770-6
22. Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995;333:693-8
23. Pegtel DM, Subramanian A, Sheen TS, Tsai CH, Golub TR, Thorley-Lawson DA. Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis. J Virol 2005;79:15430-42